Clinical studies on chronic kidney disease

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease

Red Blood Cell Lifespan

Mechanisms of Diabetic Nephropathy in Ecuador

Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial

Inulin and Protein Fermentation in Hemodialysis Patients

Karolinska Cardiorenal Theme-centre and StockholmHeartbank

Nanshan Elderly Cohort Study

Analyse Cardio-respiratory Patterns in Order to Early Detect the Clinical Complications in the Hemodialysis Patients

ADMA Levels in End-Stage Renal Disease

Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients

Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4

Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States

Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease

The Effects of Eccentric Cycling Exercise Program in Chronic Kidney Disease Patients

Skin Autofluorescence as a Risk Marker in People Receiving Dialysis

Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis